» Articles » PMID: 19521678

Altered Reward Functions in Patients on Atypical Antipsychotic Medication in Line with the Revised Dopamine Hypothesis of Schizophrenia

Overview
Specialty Pharmacology
Date 2009 Jun 13
PMID 19521678
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the mesolimbic dopamine system during expectation and receipt or omission of rewards in partially remitted patients with schizophrenia treated with the atypical antipsychotic olanzapine.

Methods: We studied 16 patients with a current episode of schizophrenia, all treated with the atypical drug olanzapine, and 16 healthy subjects using functional magnetic resonance imaging. Subjects performed a delayed incentive paradigm with monetary rewards.

Results: During reward expectation, both, patients with schizophrenia and healthy control subjects, showed activation of the ventral striatum and midbrain in the vicinity of the ventral tegmental area. Significant categorical group differences emerged in the anterior cingulate cortex with only healthy controls showing increasing activation with increasing reward. In the patients, activation of this region was inversely correlated with positive symptoms. During outcome, both, patients with schizophrenia and healthy controls, showed activation of the ventral striatum and the mesial prefrontal cortex. Significant categorical group differences emerged in the right ventrolateral prefrontal cortex for the salience contrast with healthy controls showing a U-shaped activation curve, i.e., higher activation for either omission or receipt of reward compared to no reward.

Conclusions: Our findings partially support the current concept of dopaminergic dysfunction in schizophrenia, suggesting a rather hyperactive mesolimbic dopamine system and reduced prefrontal activation, at least in partially remitted patients treated with atypical antipsychotics.

Citing Articles

The role of glial cells in mental illness: a systematic review on astroglia and microglia as potential players in schizophrenia and its cognitive and emotional aspects.

Laricchiuta D, Papi M, Decandia D, Panuccio A, Cutuli D, Peciccia M Front Cell Neurosci. 2024; 18:1358450.

PMID: 38419655 PMC: 10899480. DOI: 10.3389/fncel.2024.1358450.


Gm527 deficiency in dentate gyrus improves memory through upregulating dopamine D1 receptor pathway.

Jia J, Peng H, Tian R, Zhou H, Zheng H, Liu B CNS Neurosci Ther. 2023; 29(11):3290-3306.

PMID: 37248637 PMC: 10580352. DOI: 10.1111/cns.14259.


Insular and Striatal Correlates of Uncertain Risky Reward Pursuit in Schizophrenia.

Purcell J, Brown J, Tullar R, Bloomer B, Kim D, Moussa-Tooks A Schizophr Bull. 2023; 49(3):726-737.

PMID: 36869757 PMC: 10154703. DOI: 10.1093/schbul/sbac206.


Microglia sequelae: brain signature of innate immunity in schizophrenia.

Rodrigues-Neves A, Ambrosio A, Gomes C Transl Psychiatry. 2022; 12(1):493.

PMID: 36443303 PMC: 9705537. DOI: 10.1038/s41398-022-02197-1.


Neural substrates of reward anticipation and outcome in schizophrenia: a meta-analysis of fMRI findings in the monetary incentive delay task.

Zeng J, Yan J, Cao H, Su Y, Song Y, Luo Y Transl Psychiatry. 2022; 12(1):448.

PMID: 36244990 PMC: 9573872. DOI: 10.1038/s41398-022-02201-8.


References
1.
Abi-Dargham A . Probing cortical dopamine function in schizophrenia: what can D1 receptors tell us?. World Psychiatry. 2006; 2(3):166-71. PMC: 1525099. View

2.
Wolf R, Vasic N, Walter H . Differential activation of ventrolateral prefrontal cortex during working memory retrieval. Neuropsychologia. 2006; 44(12):2558-63. DOI: 10.1016/j.neuropsychologia.2006.05.015. View

3.
Kapur S . Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2002; 160(1):13-23. DOI: 10.1176/appi.ajp.160.1.13. View

4.
Abler B, Walter H, Erk S, Kammerer H, Spitzer M . Prediction error as a linear function of reward probability is coded in human nucleus accumbens. Neuroimage. 2006; 31(2):790-5. DOI: 10.1016/j.neuroimage.2006.01.001. View

5.
da Silva Alves F, Figee M, van Amelsvoort T, Veltman D, de Haan L . The revised dopamine hypothesis of schizophrenia: evidence from pharmacological MRI studies with atypical antipsychotic medication. Psychopharmacol Bull. 2008; 41(1):121-32. View